Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Metrics to compare | GRAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRANPeersSector | |
---|---|---|---|---|
P/E Ratio | 28.5x | 28.5x | −0.6x | |
PEG Ratio | 1.20 | 0.32 | 0.00 | |
Price/Book | 4.1x | 3.9x | 2.6x | |
Price / LTM Sales | 3.1x | 4.8x | 3.1x | |
Upside (Analyst Target) | 21.2% | 10.7% | 55.1% | |
Fair Value Upside | Unlock | −12.2% | 9.2% | Unlock |